Thermo Fisher Scientific (TMO) won approval from the European Commission to acquire Solventum's (SOLV) purification and filtration business.
The transaction relates primarily to the bioprocessing filtration sector and was approved
under a simplified review process with no competition concerns, the commission said Monday in a statement.
Thermo Fisher shares fell 1.7% in recent trading Monday, and Solventum eased 0.3%.
Price: 427.32, Change: -7.54, Percent Change: -1.74